2025 SPEAKERS
MARCH 30 - APRIL 02, 2026
WALTER E. WASHINGTON CONVENTION CENTER, WASHINGTON D.C.
Camille (Pope) Campbell, Senior Director, Health Equity, Acclinate
Kristyn Aalto, CEO, Orlance, Inc.
Erin Abramsohn, Executive Director, Infectious Disease Prevention Network (IDPN)
Thomas Acciani, Director, US Vaccine Policy, GSK
Karen Acker, Assistant Professor of Clinical Pediatrics, Weill Cornell Medicine
Amesh Adalja, Senior Scholar, Johns Hopkins University
Brinda Adhikari, Executive producer, Journalist, Former ABC News, CBS News, AppleTV+ ; Co-Host, Co-Creator, EP, Why Should I Trust You? Podcast
Haritha Adhikarla, Senior Translational Immunology Lead, CEPI
Lovisa Afzelius, Founding CEO and Chair, Apriori Bio; General Partner, Flagship Pioneering
Joe Akin, Executive Director Business Development, BlueSphere Bio
Mark Alderson, CSO, Maxvax Biotechnology
Derecka Alexander, USDA Fello, USDA
Robert Allen, Chief Scientific Officer, Invivyd
Sarah Alsuleiman, Research and Development Scientist, Athari BioSciences
Jennifer Alton, President, Pathway Policy Group
Elif Alyanak, Principal, Vaccine Policy, Avalere Health
Elif Alyanak, Principal, Avalere Health
Richard Amlot, Deputy Director, Behavioural Science and Insights, UK Health Security Agency
William Ampofo, Chief Executive Officer, National Vaccine Institute
Marty Anderson, Chief Operating Officer, Profound Research
Annaliesa Anderson, SVP and Head, Vaccine R&D, Pfizer
Asimenia Angelidou, Assistant Professor of Pediatrics,, Harvard Medical School
Jorge Armero Gimenez, Platform Development Scientist, LenioBio GmbH
Amy Aspelund, Vice President, Research & Development, Vivaldi Biosciences
Kabeer Aziz, Partner, Adjuvant Capital
Irnela Bajrovic, VP of Alliances, Jurata Thin Film, Inc.
Giulia Balconi, Investor, Adjuvant Capital
Shweta Bansal, Professor of Biology, Georgetown University
Ilona Baraniak, Associate Director, Associate Principle Consultant DCS/BPE, Cencora Pharmalex
Deborah Barbara, Chair, Strategic Advisory Board, 4basebio
Dan Barouch, Professor Of Medicine, Harvard Medical School
Miranda Baxa, Consultant, Health Policy & Insights, Economist Impact
Vaho Begoyan, Sr. Scientist Chemistry R&D, TriLink Biotechnologies
Rafik Bekkat-Berkani, Vice President, Global Medical Lead Vaccines, GSK
Inna Ben-Anat, Global Head, Manufacturing 4.0, Sanofi
Kaidre Bendjama, CSO, NEC Bio
Jenna Benefield, Associate Partner, McKinsey and Company
Georges Benjamin, Executive Director, American Public Health Association
Seth Berkley, Senior Advisor,, Pandemic Center at Brown Univertsity
Ute Bertelsmann, Country Head Pratia Germany, Pratia
Fadil Bidmos, MRC Senior (Non-Clinical) Fellow, Imperial College London
Paul Bird, Chief Medical Officer, Emeritus Research
Erwin Blomsma, Chief Executive Officer, ViroVet
Cedric Bogaert, Chief Executive Officer, myNEO Therapeutics
Aurelio Bonavia, Vaccine Development, Bill & Melinda Gates Medical Research Institute
Luigi Bonfatti, Executive Advisor, RVMC (Regionalized Vaccine Manufacturing Collaborative)
Marie Bonhomme, Director, PPD, part of Thermo Fisher Scientific
Luciana Borio, Venture Partner, A.R.C.H. Venture Partners
Maria Elena Bottazzi, Co-Director of Texas Children's Hospital Center for Vaccine Development, Baylor College of Medicine
Abby Bownas, Manager, AVAC ; Partner, NVG, NVG LLC
Richard Braatz, Edwin R. Gilliland Professor, MIT
Charlotte Bradshaw, CEO, Evrima Technologies
Michael Breen, Scientist, Tiba Biotech
Gabrielle Breugelmans, Director of Epidemiology and Data Science, CEPI
Carolyn Bridges, Director for Adult Immunization, Immunize.org
Rick Bright, Founder, Bright Global Health
Kate Broderick, Chief Science and Innovation Officer, Maravai LifeSciences
Michelle Brown, Vice President, Portfolio Lead, Oncology, Moderna Therapeutics
Sky Brubaker, Head of Preclinical Research, VitriVaxBio
Chris Buck, Senior Investigator, National Cancer institute
Ambika Bumb, Deputy Executive Director, Bipartisan Commission on Biodefense
Amelia Burke-Garcia, Director, Center for Health Communication Science, NORC at the University of Chicago
David Burkhart, CEO, Inimmune Corp
Andy Burstein, CEO, Accessible Pharmacy
Lynlee Burton, Vice President, Project Management, Infectious Diseases and Vaccines, Syneos Health
Gaurav Byagathvalli, Co-Founder and CEO, Piezo Therapeutics, Inc.
Thomas Campi, CEO, Modulant Biosciences
Paolo Casali, UT Ashbel Smith Professor and Distinguished Prof of Microbiology Immunology & Molecular Genetics, UT Health San Antonio
Danilo Casimiro, Chief Science Officer, Vaccine R&D, Sanofi
Mia Castagnero, Director, Business Development, Clinical Research IO (CRIO)
Aziz Cayli, Chief Executive Officer, Florabio A.S.
Francesca Ceddia, Chief Medical Affairs Officer, Moderna
Rochelle Chaiken, Chief Medical Officer, Vaxxas
Joan Chambers, Senior Consultant, Tufts Center for the Study of Drug Development, Tufts University Medical School
Maya Chandrasekaran, Director, Social Science Research Council
Lee-Jah Chang, Head of Clinical Development, Vaccines and Immune Therapies, AstraZeneca
Chiang-Yun Chen, Researcher, CHO PHARMA INC.
Wilbur Chen, Professor of Medicine, University of Maryland School of Medicine
Ling Chen, Professor, Guangzhou Medical University,Guangzhou, China
Robert Chen, Scientific Director, BRIGHTON Collaboration
Ghania Chikh, Senior Director, Vaccine Development, Acuitas Therapeutics, Inc.
Kati Chilikova, Manager Health Policy Research, Economist Impact
Dennis Christensen, Head of Global R&D, Croda
Shana Christrup, Senior Director, Policy, Association for Accessible Medicines
Laurence Chu, Principal Investigator, Avacare
Matthew G. Clark, Joint Project Manager, CBRN Medical, JPEO-CBRND
Hazel Clothier, Lead Epidemiologist, Vaccine Safety, Center for Health Analytics, Mudoch Childrens Research Institute
Margherita Coccia, Director, GSK
Taylor Cohen, Global Product Lead, Astrazeneca
Tonya Colpitts, AVP, Global Project Head, Vaccines, Sanofi
Charlotte Colvin, Consultant, Independent
Pär Comstedt, VP Infectious Disease Vaccine Development, Evaxion Biotech A/S
Tim Cooke, CEO, Omniose
Lisa Cornbrooks, Senior Director of National Health Campaigns, American Medical Group Association AMGA
Michelle Cortez, Senior Editor / Chief Health Correspondent, Bloomberg News
Aaron Cowley, CSO, ReciBioPharm
Taylor Craig, Associate Director, Strategic Flexibility, Parexel
James Cummings, Chief Medical Officer, Vaxart
Andrew Cwiertniewicz, Sr. Delivery Director, Fortrea
Claire Dacombe, VP Sales EMEA & APAC, 4basebio
Bryan Dalphy, Deputy Director, Health Emergency Readiness Canada
Steven Damon, CEO, Micron Biomedical
Jonathan Daniels, US Policy Director, AMR Action Fund
Rituparna Das, Therapeutic Area Head, Respiratory Vaccines, Moderna
Kashmira Date, Senior Director, Medical & Scientific Affairs (Pipeline Vaccines), pfizer
Monal Daterao, Research Assistant, NYU
Mario Davinelli, Executive Director, Vaccines, Government and Public Health Services, Thermo Fisher Scientific
Sugato De, VP, Regulatory Strategy, Head of MedTech, Allucent
Johann de Bruyn, CEO, TASK Clinical Trials
Guy De La Rosa, CMO, Curevo Vaccine
Michel De Wilde, Former Senior Vice President R&D Of Sanofi Pasteur & Owner, MDW Consultant LLC
William Decker, Professor, Baylor College of Medicine
Tesfaye Dejene, Contracts Specialist, UNICEF Supply Division
Don Diamond, Director, Division of Vaccine Research & Professor, Dept of Hem & HCT, City of Hope Comprehensive Cancer Center
Antonio DiGiandomenico, Senior Director, Head of Microbial Antibodies and Technologies, Early Vaccines and Immune Therapies, AstraZeneca
Kyle Doolan, Director of Research, Integral Molecular
Macaya Douoguih, Vice President, Therapeutic Area Head, Vaccines Clinical Research, Merck Research Laboratories
Paul Dowling, Senior Supply Chain Advisor, USAID Presidents Malaria Initiative
David Dowling, Assistant Professor of Pediatrics, Harvard Medical School; Precision Vaccine Program, Division of Infectious Diseases, Boston Children's Hospital
Ruxandra Draghia-Akli, Executive Vice President, Head of Research and Development, Novavax
Patrick Duffy, Laboratory Chief, NIAID, NIH
Peter Dull, Deputy Director, Integrated Clinical Vaccine Development, Vaccine Development, Global Health Division, Gates Foundation
Anna Durbin, Professor, Johns Hopkins Bloomberg School of Public Health
Sheetij Dutta, Chief Laboratory of Structural Vaccinology, Biologics Research and Development Branch, Walter Reed Army Insitute of Research
Susanne Eder-Lingelbach, VP Clinical Development, Valneva
Darin Edwards, Executive Director, COVID Vaccines Program Leader, Moderna Therapeutics
Michael Egan, CEO/CSO, CastleVax
Angela Eichler, Director, Specialty Lab Services, JCCT
John El-Attrache, Director of Scientific Services, CEVA santé Animale
Pernille Elverdal, SrVP, Global RA, Clinical Evidence,Medical affairs, SSI Diagnostica A/S
Mark Emalfarb, Chief Executive Officer, Dyadic International Inc
Minsang (Min) Eom, Marketing Team Leader, LG Chem
Karen Ernst, Program Director, Voices for Vaccines
Aaron Esser-Kahn, Professor, University of Chicago
Steven Evans, Chief Scientific Officer, NTx
Jay Evans, Chief Scientific and Strategy Officer, Inimmune
Daniel Faissol, Principal Investigator, Center for Bioengineering, Executive Director, Predictive Design of Biologics, Lawrence Livermore National Laboratory
William Falstich, Vice President, Global Supply Chain, Primary Care, Pfizer
Donna Farber, Chief, Division of Surgical Sciences and Professor of Microbiology & Immunology, Columbia University
Matt Feldman, Communications Consultant, InTheDistance Media, LLC
Jasmin Fertey, Head Vaccine Technologies Unit, Fraunhofer-Institute for Cell Therapy and Immunology
Amy Finan, Chief Executive Officer, Sabin Vaccine Institute
Olivera (Olja) Finn, Distinguished Professor, Department of Immunology, University of Pittsburgh
Michelle Fiscus, Chief Medical Officer, IQVIA
Jaime Flores-Riveros, CSO, AmerStem
Robert Forgey, President & Chief Executive Officer, Iaso Therapeutics, Inc.
Cyrielle Fougeroux, Project Manager, adaptvac
Stephen Framil, Corporate Global Head of Accessibility, Merck & Co. Inc.
Brayden Fraser, Chief Development Officer, Emeritus Research
Stine Friis, Director, Business Development, Evaxion Biotech A/S
Michael Ganio, Senior Director, Pharmacy Practice and Quality, American Society of Health System Pharmacists ASHP
Claudia-Nanette Gann, Vice President Clinical Development, BioNTech
Pascal Geldsetzer, Assistant Professor of Medicine, Stanford University
Bruce Gellin, Professor of Medicine, Georgetown University School Of Medicine
Rebecca Gentile, Director, Biologics AR&D, Merck
Volker Gerdts, Director and Chief Executive Officer, VIDO
Khatuna Giorgadze, Partner, Linksbridge SPC
Douglas Gladue, Vice President Veterinary Pharmaceutical Development, Seek Labs
Devasena Gnanashanmugam, Vice President-Medical Affairs, Cepheid
Christy Godwin, Senior Vice President, Strategic Partnerships, Velocity Clinical Research
Monica Goel, President and Co-Founder, Unified Accessibility
Steven Gold, CEO, Boost Biopharma
Jimmy Gollihar, Head of Antibody Discovery and Accelerated Protein Therapeutics (ADAPT), Houston Methodist Hospital
Alejandra Goncalves, Senior Manager, Medical Affairs, Bavarian Nordic
Justin Goodarz, Chief Commercial Officer, Verified Clinical Trials
Nisha Gopal, Laboratory Operations Technical Manager, Revvity
Sebastian Goy, CEO, EBViously
Sebastian Goy, CEO, EBViously
Simon Graham, Co-Director, IVVN & Group Leader, The Pirbright Institute
Marion Gruber, Vice President of Public Health and Regulatory Affairs, IAVI
Swati Gupta, VP, Head of Emerging Infectious Diseases and Epidemiology, International AIDS Vaccine Initiative
Alejandra Gurtman, Sr VP, Vaccines Clinical R, Pfizer
Javier Guzman, Division Chief, Inter-American Development Bank
Bassam Hallis, Deputy Director, Vaccine Development & Evaluation Centre, UK Health Security Agency
Michinari Hamaguchi, Director General, AMED SCARDA
Melinda Hamer, Operating Partner, Global Health Investment Corporation
David Hamer, Professor of Global Health and Medicine, Boston University School of Public Health
Gyoonhee Han, Professor, K-NIBRT
Claire Hannan, Executive Director, Association of Immunization Managers
Christian Tientcha Happi, Professor of Molecular Biology and Genomics in the Department of Biological Sciences & Director, ACEGID
Christian Harding, CSO & Co-founder, Omniose
Chandresh Harjivan, Chief Strategy Officer, The Medical Countermeasures Coalition
Jenny Harries, Chief Executive Officer, UK Health Security Agency
Renee Hart, President & CBO, LumaCyte
Ian Hart, Manufacturing Lead, CEPI
Kathryn Hashey, Global Vaccine Policy & Government Affairs, GSK
Bill Hausdorff, Lead, Meningococcal Vaccine Development and Vaccines Public Health Value Proposition and, PATH, Center for Vaccine Innovation and Access
Jian (Jason) He, Executive Director, Head of BD and CMC, WuXi Vaccines
Jonathan Heeney, Chief Scientific Officer, DIOSynVax Limited
Antonio Hellebuyck, Senior Director, Project Oversight, Thermo Fisher Scientific
Caroline Heller, Chief Business Officer, Rumin8
Jennifer Heller, Partner, McKinsey and Company
Klaus Hellmann, Head of Europe CRO, Argenta
Ana Maria Henao-Restrepo, Lead R&D Blueprint for epidemics, Health Emergencies Programme (WHE),, World Health Organisation
Lisa Hensley, Distinguished Senior Research Scientist Research Lead - Zoonotic and Emerging Disease Research Unit, USDA
Matthew Hepburn, Chief Medical Officer, JPEO-CBRND
Susan Hepworth, Executive Director, National Coalition for Infant Health
Jaime E Hernandez, Executive Medical Director, Clinical Development, Syneos Health
Lisa Herron-Olson, MD, Syntiron
Damian Hiley, Business Development Vaccine Adjuvants, Desert King
Adrian Hill, Director and Professor, The Jenner Institute - University of Oxford
Rick Hill, President, IABS
Tim Hirst, CEO, GPN Vaccines Ltd
Hiwot Hiruy, Director, Clinical Development, Infectious Disease, Moderna
Catherine Hoath, Global Regulatory Strategy Lead, CEPI
James Hodge, Jr., J.D., LL.M, Peter Kiewit Foundation Professor of Law, Director, Center for Public Health Law and Policy, Arizona State University
Erin Hodges, Global Medical Product Lead, Beyfortus, Sanofi
Bernard Hoet, Vice President of Medical Strategy, Bavarian Nordic A/S
Stephen Hoffman, Chief Executive And Scientific Officer, Sanaria
Kevin Kee-Jong Hong, Professor, KOREA mRNA VACCINE INITIATIVE (KmVAC)
Rocio Honigmann, Chief Executive Officer, Amerstem Inc
Peter Hotez, Professor, Baylor College of Medicine
Pamela Housh, Senior Director of Business Development, Eyam Health
xuefei huang, professor, Michigan State University
Richard Hughes IV, Partner, Epstein, Becker & Green, The George Washington University Law School
David Humphreys, Executive Advisor, Triangulate health Ltd
Lucas Huntimer, CSO, Genvax Technologies
Lecia Imbery, Government Affairs Director, Vaccinate Your Family
Praneel Jadav, Manager, Infectious Disease Policy, BIO
Manish Jain, Principal Investigator, Flourish Research
Juan Carlos Jaramillo, Chief Medical Officer, Valneva
Hyonjin Jeon, Consultant, Shift Health
Mark Jit, Chair and Professor, Department of Global and Environmental Health, New York University
Elizabeth Joseph, Research Scientist II, Simtra BioPharma Solutions
Gordon Joyce, Chief Structural Biology, EIDB Research
Chrissie Juliano, Executive Director, Big Cities Health Coalition
Stella Hyesun Jun, Director of BD, QuadMedicine, Inc.
Andrew Jurgensen, Senior Global Project Manager, Accelerated Enrollment Solutions (AES)
Ashley Kalinauskas, Founder, Torigen Pharmaceuticals
Ramaswamy Kalyanasundaram, Professor Microbiology and Immunology, University of Illinois
Robert Kaminski, Consultant, World Health Organization
Maria Karasarides, Former Vice President, Worldwide Medical Oncology, Early Assets & Biomarkers, The Delphina Group
Nektaria Karavas, Director Business Development, Aptar Pharma
Sarah Karlin-Smith, Senior Writer, The Pink Sheet
Anne Kasmar, Senior Vice President, Global Therapeutic Head, Infectious Disease and Vaccines, Parexel
Aemro Kassa, Senior Associate Director, Viral Vaccine Exploration, Boehringer Ingelheim Animal Health
David Kaufman, Partner, Third Rock Ventures
Pravin Kaumaya, Professor & Director, Indiana university School of Medicine
Sheila Keating, Vice President Immunology, GigaGen Inc
Chase Kempinski, Chief Executive Officer, EVAX Inc.
Kent Kester, Executive Director, Vaccine Research and Development, CEPI
Hannah Kettler, Head of Global Health Security, GAVI, The Global Alliance for Vaccines and Immunization
Musaddiq Khan, VP, Customer Value - Digital Outcomes & TA Strategy, Medable
Anjalee Khemlani, Senior Reporter, Yahoo! Finance
Kevin Killeen, Chief Scientific Officer, Matrivax R & D Corp
Jerome Kim, Director General, IVI
Hani Kim, Executive Director, RIGHT Foundation
Seokkyu Kim, Director, EuBiologics Co., Ltd.
Alasdair King, Executive Director, International Veterinary Health, Merck Animal Health
Neville Kisalu, Senior Scientist Cellular Immunology Section, Vaccine Research Center, NIH - National Institute of Allergy and Infectious Diseases
Sabra L Klein, Professor of Molecular Microbiology and Immunology, Johns Hopkins Bloomberg School of Public Health
Charles Kline, Associate Vice President, Merck
Dinah Knotts-Keeterle, Vice President, Project Management, Vaccines/Infectious Diseases, ICON PLC
Alana Knudson, Director, NORC Walsh Center for Rural Health Analysis
Selçuk Koçhan, Co-Founder & CEO, MOBIQU
Jessica Kogan, Principal Scientist, Regulatory Affairs CMC, Merck And Co Inc
Kazuya Kominami, Section Manager, Hisamitsu Pharmaceuticals
Kathryn Kosuda, CSO, Vaxess Technologies
Tristan Kovačič, Project Manager, Sartorius BIA Separations
Michael Kowarik, CSO, LimmaTech Biologics AG
Phil Krause, Consultant and Former FDA, Independent
Lakshmi Krishnan, Vice-President, Life Sciences, National Research Council Canada
Mahesh Kumar, Senior VP, Global Biologics R&D, Zoetis
Arvind Kumar, Vice President of Research, BiomEdit
Prabuddha Kumar Kundu, Co-founder and MD, Premas Biotech
Craig Laferriere, CSO, iosBio Ltd
Rekha Lakshmanan, Chief Strategy Officer, The Immunization Partnership
Michael Lambin, Development Technical Lead Manager, Exothera
Kevin Lang, Senior Research Scientist, Laboratory Services Bioanalytical Lab, PPD, part of Thermo Fisher Scientific
Paul Lawrence, Director of Research and Development, Bimeda
Luigi Lay, Lecturer -Department of Chemistry, University of Milan
Jessica Lazerov, Pediatrician, Children's National Hospital
Alexandre Le Vert, Chief Executive Officer, Osivax
Amanda Leach, Director Clinical Development, PATH
Jungseok Lee, Head of Policy & Economic Research Department, Shift Health
Myron (Mike) Levine, Professor, University of Maryland School of Medicine
Ofer Levy, Director, Precision Vaccines Program, Boston Children's Hospital
Jay Lieberman, Senior Medical Director, Parexel
Dave Liebowitz, Senior Vice President, Early-Stage Clinical Development, Inovio
Elizabeth Linderbaum, Deputy Director of Regulatory Affairs,, National Association of Community Health Centers Inc
Thomas Linnekin, Scientist I, SeromYx Systems
Fernando Lobos, Business Development Director, Sinergium Biotech
Rushit Lodaya, RNA Delivery and formulations lead, GSK
Sarah S. Long, Emeritus Chief, Infectious Diseases, St. Christopher’s Hospital for Children; Past member, ACIP, VRBPAC, Professor of Pediatrics, Drexel University College of Medicine
Nicolette Louissaint, Senior Vice President, Policy and Strategic Planning, The Healthcare Distribution Alliance
Catherine Lund, VP Strategic Development Africa, P95
Marie-Louise Lunn, Global Senior Product Manager, Novo Nordisk Pharmatech
Angela Luttick, EVP Commercial, 360biolabs
Janeen Madan Keller, Policy Fellow & Deputy Director for Global Health, Center for Global Development - Washington, DC
Tom Mahoney, Immunology and Infectious Diseases, Harvard T.H. Chan School of Public Health
Arman Majidulla, Assistant Scientist, Johns Hopkins Bloomberg School of Public Health
Jessica Malaty Rivera, Science Communication Advisor, PGP (The Public Good Projects)
Shelly Malhotra, Vice President Global Access & External Affairs, IAVI
Dan Mallon, SVP Corporate Development, PharmaJet
Dominic Mancini, Vice President, Operations, OrganaBio
Christian Mandl, CSO, Tiba Biotech
Kathleen Mandziuk, Vice President, Project Management, ICON PLC
Alessandro Manenti, Chief Development Officer, Vismederi
Alex Mann, Director, Hvivo
Monique K. Mansoura, Executive Director, Global Health Security & Biotechnology, Independent
Judy Maro, Associate Professor of Population Medicine, Harvard Medical School
Gerben Marsman, Head of Alliance Management, Vaccine Formulation Institute
Rebecca Martin, Vice President for Global Health, Emory Global Health Institute, Emory University
Vega Masignani, Alliance Director, CARB-X
Nicola Mason, Paul A. James and Charles A. Gilmore Endowed Chair Professorship, Professor of Medicine, University of Pennsylvania School of Veterinary Medicine
John Mattison, Operating Partner, Chief Medical Information Officer, Arsenal Capital Partners
Jeremy Maurer, Associate Director - Insights and Outcomes, Merck Animal Health
Luciana Maxim, Director, Health Supply Chain & Lab Systems, VillageReach
Matthew Maxwell, Chief Growth Officer, Centricity Research
Alison M Buttenheim Mba, Professor, University of Pennsylvania
Bryanna McDermott, Senior Director, Vaccine Program Delivery, Nucleus Network Pty Ltd
Mary Jane McNamee, Dir. of Scientific & Regulatory Affairs, Animal Health Institute
Justine McPartlan, Scientist, Tiba Biotech
Yimy Mena, CEO and Director of Process Development, Pegasus Biotech Inc.
Kate Mevis, Executive Director, Vaccines Public Policy, Merck
Romain Micol, CEO, Combined Therapeutics
Francesca Micoli, Director GVGH Innovation Academy and Senior Project Leader, GVGH
Shannon Miller, VP Operations, Inimmune Corporation
Michael Miller, Consultant - Author, HealthPolCom
Jamie Minchin Reedy, Infectious Disease Project Manager, USAID
Kayvon Modjarrad, Executive Director, Viral Vaccines, Pfizer
Lenny Moise, VP, Research, SeromYx
Hajir Mokhtari, Director, Business and Commercial Operations, Thermo Fisher Scientific
Nicolas Moniotte, Chief Technology Officer, Quantoom
Barney Montgomery, CEO, Optimal Clinical Trials Ltd
Ruth Montgomery, Professor, Yale University
Christopher Morgan, Technical Director, Immunization, Jhpiego
J. Stephen Morrison, Senior Vice President and Director, Global Health Policy Center, Center for Strategic and International Studies
Sarah Moselle, Sr Director, Avalere Health
Sally Mossman, VP, Head of Research Portfolio Strategy, Sanofi Vaccines
Seranne Motilal, Technical Manager, Clinton Health Access Initiative
Hypolite Muhindo Mavako, Professor, Department of Tropical Medicine, University of Kinshasa
Iona Munjal, Executive Director, Vaccine Clinical Research and Development, pfizer
Flor Munoz, Associate Professor Of Pediatrics-Infectious Disease, Baylor College of Medicine
Marta Murreddu, Business Development Manager, Cerba Research
Usman Nakakana, Senior Program officer vaccine development and impact, Gates Foundation
Sujatha Narayan, Principal Regulatory Program Director, Genentech
Farooq Nasar, Director of Virology, Research and Development Center, Tonix Pharma
Tiffany Nation, Head of Regulatory Affairs Biologicals, US and Primary Market, Boehringer Ingelheim Animal Health USA Inc
David Nees, VP Business Development, eEnzyme
Jonas Nguh, Immediate Past President, Maryland Public Health Association
Dale Nordenberg, Digital Transformation Lead, BRIGHTON Collaboration
Brian Nunnally, Vice President and Enterprise Head of Quality Control, CSL
Christian Ockenhouse, Senior Program Officer, Malaria, Gates Foundation
Ahmed Ogwell, Senior Advisor, United Nations Foundation
Derek O'Hagan, Senior Advisor in R&D, GSK Vaccines
Saad Omer, Dean, Peter O’Donnell Jr. School of Public Health, The University of Texas Southwestern Medical Center
Walter Orenstein, Professor Emeritus, Emory School of Medicine, Former Associate Director,, Emory Vaccine Center
Masaru (Rusty) Oshita, MD, Apex Research Group / QCR Network
Julia Oswald, Senior Director, Project Management, PPD Clinical Research Business, Thermo Fisher Scientific
Nupur Parikh, Policy Manager, Health, The ONE Campaign
Rachel Park, Director, EuBiologics Co
Sylvia Park-Ekecs, Global Head of Consumer eXperience + Design | CXO | Group SVP, Sanofi
dimki patel, CMC program lead, CEPI
Sandeep Patel, CEO, Humanity Health Ventures
Heenal Patel, Head of Strategic Partnerships, Paratus Clinical
Mayur Patel, VP Global R&D Product Development and Portfolio Management, Elanco
Gabriela Paz-Bailey, Chief of the Dengue Branch, CDC
Martin Pech, Senior Manager Development and Head of Manufacturing, IDT Biologika
Cathy Peters, Strategic Director, State & Local Campaigns - Access to Care, ACSCAN
Nikolai Petrovsky, Chairman, Vaxine Pty.
Michael Pfleiderer, Senior Director, Principal Consultant DCS/BPE, Cencora Pharmalex
May Pidding, Director, Microneedle Array Patch Product Management, LTS Lohmann
Joel Pinkham, VP Strategic Initiatives and Growth, HealthMatch
Amy Pisani, Chief Executive Officer, Vaccinate Your Family
Stanley Plotkin, Emeritus Professor, University of Pennsylvania School Of Medicine
Gregory Poland, Director of Mayo Vaccine Research Group, Mayo Clinic
Robert Popovian, Chief Science Policy Officer, Global Healthy Living Foundation
Jay Pottala, Associate Biostatistics Director, ppd
Nakorn Premsri, Director, National Vaccine Institute
Stanley Prince, CCO, PathoQuest
Simon Procter, Assistant Professor, London School of Hygiene and Tropical Medicine
Bali Pulendran, Director, Institute for Immunity, Transplantation and Infection, Stanford University School of Medicine (USA)
Lisa Purcell, Entrepreneur-In-Residence, Third Rock Ventures, LLC
Kedar Purnapatre, Director-Bioanalytical Operations, Aragen Lifesciences Ltd
Amy Purse, Biological Regulatory Affairs Advisor, Elanco
Martin Rabel, Global Sales Specialist | Biopharma Services, Cytiva
Paul Radspinner, CEO, FluGen Inc
Marlen Ramirez, CHW/CHWI, Programs Coordinator, Vaccinate Your Family
Irina Ramos, Senior Distinguished Scientist CMC and Innovation, Johnson & Johnson
Raman Rao, Chief Executive Officer, Hilleman Laboratories Singapore Pte Ltd
Rino Rappuoli, Scientific Director, Fondazione Biotecnopolo di Siena
Megan Rauscher, Senior Manager, ThinkWell
Joren Raymenants, Postdoctoral Clinical Researcher, University of Antwerp Vaccinopolis
Hugo Razuri, Deputy Manager, Comprehensive Immunizations, PAHO
Elizabeth Reap, Head of TSAIL, IQVIA
Dakshina Reddy, Head of Global Regulatory Strategy and Operations, Bill & Melinda Gates Medical Research Institute
Max Reinertsen, Head of Business Strategy & Operations, Artyc
Shon Remich, MD, and CMO,, ARMR Sciences
Nicole Revie, Senior Consultant, Shift Health
Hagen Richter, Head of Nucleic Acids Research, Wacker Biotech
Giovanna Riggall, Head of Heath Supply Chain, Unimed
Bridget Ristagno, Vice President Clinical Operations, PanAmerican Clinical Research
Ruben Rizzi, SVP Global Regulatory Affairs, BioNTech SE
Edward J Robb, Chief Strategy Officer, Anivive Lifesciences
Jeffrey Roberts, Associate Vice President, Vaccine GCD, Merck
Michelle Roberts, Head of medical RSV Franchise, Vaccines, Sanofi
Joanie Robertson, Program Advisor, PATH
Kate Rochlin, Chief Operating Officer, IN8bio
Mario Rodriguez, Sr Director MCM, Emergent Biosolutions
Carla Rodriguez-Watson, Director of Research, Reagan Udall Foundation for the F.D.A.
David Rogers, CEO, MEU
Birgitte Rønø, Chief Scientific Officer, Evaxion Biotech A/S
Sarah Rosen, Senior Director, Non-Interventional Studies, Thermo Fisher Scientific
Zeil Rosenberg, Executive Vice President, Medical, Tonix Pharmaceuticals
Candice Roux, Program Manager: Grants, Innovation and Product Development, South African Medical Research Council
Debra Ruh, CEO and Founder, Ruh Global IMPACT
Olli Rundgren, CEO & Founder, Psyon Games
Kevin Russell, Associate Vice President, Global Clinical Development, Vaccines, Merck Research Laboratories
Jerald Sadoff, Chief Medical Officer, Centivax
Jen Saenz, Executive Vice President, Pharmacy and eCommerce, Albertsons Companies
Sushant Sahastrabuddhe, Deputy Director General, Shift Health
Fama Sakho, Global South Fellow from IPD, CEPI
Vivek Sakhrani, Vice President, Atlas AI
Daniel Salmon, Director, Institute for Vaccine Safety, Johns Hopkins Bloomberg School of Public Health
Tarun Saluja, Head of Clinical Development, Shift Health
Tyler Sandberg, Product manager, MABTECH
Catherine Sanders, VP, Business Development, Ozette Technologies
Alcir Santos Neto, Manager Health Policy Research, Economist Impact
Gautam Sanyal, Principal Consultant, Vaccine Analytics, LLC
Niranjan Sardesai, President & Chief Executive Officer, Founder, Geneos Therapeutics
Giuseppe Sautto, Assistant Professor, Cleveland Clinic
Cheri Savercool, Associate Director, Site Alliances, Therapeutic Networks, Parexel
Darja Schmidt, Principal Scientist, Assay Dev, IQVIA
Alexander Schmidt, Head of Development and Chief Medical Officer, Bill & Melinda Gates Medical Research Institute
Lewis Schrager, Former Senior Leader, TB Impact Area, IAVI, Independent
Hanneke Schuitemaker, CSO, Valneva Austria GMBH
Joachim Seipelt, CBO, Nuvonis Technologies GmbH
Rafick-Pierre Sékaly, Professor and Vice-Chair of Translational Medicine, Emory University - School of Medicine
Angamuthu Selvapandiyan, Professor, Jamia Hamdard
Alessandro Sette, Professor, La Jolla Institute for Allergy and Immunology
Taylor Sexton, Executive Director, Medical Countermeasures Coalition, Todd Strategy Group
Angela Shen, Consultant, University of Pennsylvania
Lindsey Shields, Deputy Director, Epidemic Prepardness and Response, PATH
Lora Shimp, Director - Immunization Center, John Snow Inc
Fadwa Sibai, Director International Policy & Public Affairs Antivirals and Internal Medicine, Pfizer
George Sigal, CSO, Meso Scale Diagnostics
Natalie Silmon De Monerri, Director, Pfizer
Derrick Sim, Chief Vaccine Programmes & Market Officer, GAVI, The Global Alliance for Vaccines and Immunization
Anushua Sinha, Sr Principal Scientist, Clinical Research, Merck and Co.
Robert Sitrin, Senior Scientist, PATH
Jeffrey Skolnik, Senior Vice President, Clinical Development, Inovio Pharmaceuticals
Lori Sloate, Former Sr Director UN Foundation; CEO Sloate & Associates, Sloate & Associates
William Smith, CEO, AMR
Denise Smith, Inaugural Executive Director, National Association of Community Health Workers
Igor Smolenov, Chief Development Officer, Arcturus Therapeutics
Joe Smyser, Chief Executive Officer, PGP (The Public Good Projects)
Pilar Snowden, Medical Director, RSV, GSK
Jonathan E Snyder, Senior Advisor, External Innovation, Elanco
Elizabeth Sobczyk, Associate Executive Director, Post-Acute and Long-Term Care Medical Association (PALTmed)
Wendy Sohn, Executive Dir,, Moderna
Fenan Solomon, Director, Market Access & Payment Policy Diagnostic Solutions and Specimen Management Public Affairs, BD
José Martín Solórzano González, Scientific Coordinator, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol (IDIAP )
Manki Song, Deputy Director General of Science, Shift Health
Nick Spittal, Chief Operations Officer, Velocity Clinical Research
Geetha Srinvas, Director, CVB, USDA
Nick Stamatakis, President, Meraki Consultants LLC
Citseko Staples Miller, Managing Director, Public Affairs, FTI Consulting, Inc.
Mike Stebbins, Sr. Vice President, ATI - Advanced Technology International
Ann-Muriel Steff, Program Lead, CEPI
Katy Stein, Virology Scientist, Microbiologics
Katarina Stenklo, Senior Product Manager, Cytiva
Julia Stephanus, Partner, Borealis Ventures
Erin Strait, Chief Scientific Officer, Dalan Animal Health
Walter Straus, Vice President, Clinical Safety & Risk Management, Moderna Therapeutics
Tate Stubbs, Chief Operating Officer, HealthMatch
Vic Suarez, Principal Growth Partner, Blu Zone Bioscience
Adriana Suenaga, Senior Director, Integrated Solutions Strategy, Parexel
Julie Suman, Vice President, Scientific Affairs, Aptar Pharma
Rajinder Suri, Chief Executive Officer, Developing Countries Vaccine Manufacturers Network
Litjen (L.J) Tan, Chief Policy and Partnerships Officer, Immunize.org
Ryo Tanaka, Senior Research Scientist, Terumo
Nigel Temperton, Professor and Director, University of Kent
Petro Terblanche, Chief Executive Officer, Afrigen Biologics (Pty) Ltd
Sanchia Theron, Executive Director, Business Development, FHI Clinical
Patrick Thiaville, VP, 4basebio
Stephen Thomas, Director, Upstate Global Health Institute, New York Upstate Medical University
Douglas Thomson, Venture Partner, Kineticos Life Sciences
Thomas Tillett, Chief Executive Officer, MBF Therapeutics
Luke Tina, Director and Principal Investigator, Victoria Biomedical Research Institute
Boghuma Titanj, Assistant Professor of Medicine, Division of Infectious Diseases, Emory University - School of Medicine
Pooja Tiwari, Co-founder & CEO, ARNAV Biotech
Franklin Toapanta, Associate Professor, University of Maryland
Gregorio Torres, Head of Department, World Organisation for Animal Health
Harout Tossonian, Director, Global Medical Affairs Lead, Latent Viruses - CMV, Moderna
Laura Treml, SVP, Companion Animal, Phibro Animal Health Corporation
Vianney Tricou, Senior Director, Medical & Scientific Affairs, Takeda Pharmaceuticals International AG
Alexa Trost, Senior Consultant, Access Partnership
Chia-Wei Tsai, Vice President, Mapp Biopharmaceutics
Sean Tucker, CSO, Vaxart
Jennifer Urwongse, DCT Strategy & Innovation Director, Thermo Fisher Scientific
Isaac Uwins, Senior Analyst, Airfinity
Sander van Asbeck, CEO and Co-Founder, RiboPro
Wouter van den Braak, Business Development Associate, Intravacc
Robert van der Put, Director Business Development, Intravacc
Tyler Van Horn, Chief Executive Officer, Science 37
Katie Van Tornhout, Founder, Callie Cares
Roland Ventura, VFI Senior Advisor for Strategy, Vaccine Formulation Institute
Thomas Verstraeten, CEO, P95
Patricia Vietheer, Director R&D Strategy and Planning, Biointelect Pty Ltd
Dr Tonya Villafana, Vice President, Franchise and Medical & Scientific Affairs, AstraZeneca
Felipe Villalobos, Scientific Coordinator, Fundació Institut Universitari per a la recerca a l'Atenció Primària de Salut Jordi Gol (IDIAP )
Ian Villamagna, Sales Specialist- DNA & RNA Therapeutics, Sartorius
Will Walters, Attorney, Epstein Becker & Green P.C.
Guoan Wang, Ph.D. - Director of Process Development,, uBriGene Biosciences
Peter Wang, Director of Marketing and Business Development, BioStone Animal Health
SOAZIC ELISE WANG SONNE, Economist, World Bank Group
Kelly Warfield, President, R&D, Sabin Vaccine Institute
Wesley Warren, Executive Director, Translational Research, City of Hope
James Wassil, COO, Vaxcyte
Kevin Webb, COO, API Innovation Center
Richard Webby, Director, World Health Organization Collaborating Centre for Studies on the Ecology of Influenza in Animals and Birds, St. Jude Children's Research Hospital
David Weiner, Executive Vice President: Director of Vaccine and Immunotherapy Center, The Wistar Institute
Kerri Weingard, Cofounder, VP & Global COO, Verified Clinical Trials
David Weiss, Director Corporate Development, Telesis Bio -
Trevor Wellington, Director, Clinical Trials Center, Walter Reed Army Institute of Research
Kasondra White, Acting Director General, Health Emergency Readiness Canada
Alvaro Whittembury, Regional Advisor, Immunization Advisor, Comprehensive Immunizations, PAHO
Wassana Wijagkanalan, Director, Discovery BioNet, Bionet
Annelies Wilder-Smith, Team Lead, Department of Immunisation, Vaccines and Biologicals, WHO
Adam Williams, Sr Director, Pandemic Preparedness Commercial Lead, Pfizer
Craig Williams, CEO, Apriori Bio
Gregg Wilson, Director of Scientific and Medical Affairs, PharmaJet
Seanette Wilson, Senior Programme Manager, Biovac Institute
Allison Winnike, Director, Western Region, The Network for Public Health Law
Markus Winterberg, Head of Analytical Development, Microbiology, and Quality Control, LTS Lohmann
Thad Wolfram, Chief Strategy Officer, EmVenio
Tuck Seng Wong, Director, UK-SEA Vax Hub; Professor of Biomanufacturing, University of Sheffield
Andrew Wong, Senior Advisor to the Board, Walvax
Edward Wright, President, ICON Government and Public Health Solutions Inc., ICON PLC
Sander Wuyts, ImmuneWatch, ImmuneWatch
Prashant Yadav, Senior Fellow, Council on Foreign Relations
Ravi Yalamanchili, AVP Digital and Data Products, Merck
Khaled Yamout, Advisor, Primrose BIo
Y. Tony Yang, Professor, The George Washington University
Justin Yang, Advisor, Global Health Investment Corporation
Diana Yassanye, Co-Founder, Parasol Health Consulting
Emily Young, Head of Non-Viral Delivery, 4basebio
Alan Young, Chief Technology Officer, Medgene Labs
Roland Zahn, Senior Director, Head Nonclinical and Translational Immunology, Communicable Diseases, J&J Innovative Medicine
Larry Zeitlin, President, Mapp Biopharmaceutical, Inc.
Jason Zhang, Chief Executive Officer and Co-Founder, Zipcode Bio
Mauricio Zuma Medeiros, Chief Executive Officer, Bio-Manguinhos, Fiocruz
Created by
Terrapinn is proud to be a member of isla.
Working together to build sustainable events